Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Non Operating Income: 2009-2025

Historic Other Non Operating Income for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $6.1 million.

  • UNITED THERAPEUTICS's Other Non Operating Income rose 5.17% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$900,000, marking a year-over-year decrease of 111.54%. This contributed to the annual value of $5.8 million for FY2024, which is 141.43% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Other Non Operating Income of $6.1 million as of Q3 2025, which was up 6,200.00% from -$100,000 recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Other Non Operating Income registered a high of $97.2 million during Q1 2021, and its lowest value of -$51.8 million during Q2 2022.
  • Over the past 3 years, UNITED THERAPEUTICS's median Other Non Operating Income value was -$600,000 (recorded in 2023), while the average stood at -$590,909.
  • Over the last 5 years, UNITED THERAPEUTICS's Other Non Operating Income had its largest YoY gain of 1,017.24% in 2021, and its largest YoY loss of 23,400.00% in 2021.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Other Non Operating Income stood at -$28.8 million in 2021, then surged by 81.60% to -$5.3 million in 2022, then soared by 88.68% to -$600,000 in 2023, then tumbled by 333.33% to -$2.6 million in 2024, then climbed by 5.17% to $6.1 million in 2025.
  • Its last three reported values are $6.1 million in Q3 2025, -$100,000 for Q2 2025, and -$4.3 million during Q1 2025.